Structure of CEA 605-613 mutant (HLA-A*02:01) 610D
Logo for Cancer
Cancer

CEA 605-613 mutant (HLA-A*02:01) 610D YLSGADLNL

Product number: EP11112_1

€105.00*

Prices excl. VAT plus shipping costs
Available, delivery time: 1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Caution: For research use only. Not for use in humans.
Amount in mg
1
Add to Cart

Description

The peptide CEA 605-613 mutant (HLA-A*02:01) 610D with the amino acid sequence YLSGADLNL is a linear peptidic epitope (epitope ID 2218585) studied as part of Cell adhesion molecule CEACAM5 (UniProt:P06731) from Homo sapiens (human).

The epitope is an analog of: YLSGANLNL from Homo sapiens (human) Carcinoembryonic antigen-related cell adhesion molecule 5.

CEA 605-613 mutant (HLA-A*02:01) 610D has been studied for immune reactivity in publications and has been tested in T cell assays.

TechData

Sequence: YLSGADLNL
Gene: CEACAM5
Delivery: 1-3 days
C-Terminus: OH
N-Terminus: H
Amount: 1 mg
Counterion: TFA
Protein: Carcinoembryonic antigen-related cell adhesion molecule 5
Species: Human
Allele: HLA-A*02:01
Application: Flow Cytometry
Indication: Cancer
Purity: 95% HPLC-MS